Renol Polychem Ltd logo

Renol Polychem IPO

  • Status: Closed
  • RHP:
  • ₹ 240,000 / 2400 shares

    Minimum Investment

IPO Listing Details

  • Listing Date

    07 Aug 2025

  • Listing Price

    ₹ 105.00

  • Listing Change

    0.00%

  • Last Traded Price

    ₹ 145.00

Renol Polychem IPO Details

  • Open Date

    31 Jul 2025

  • Close Date

    04 Aug 2025

  • Listing Date

    07 Aug 2025

  • IPO Price Range

    ₹ 100 to ₹105

  • IPO Size

    ₹ 24.20 Cr

  • Listing Exchange

    NSE SME

Open Free Demat Account

+91

By proceeding, you agree to all T&C*

hero_form

Renol Polychem IPO Subscription Status

Last Updated: 04 August 2025 6:49 PM by 5paisa

Founded in 2008, Renol Polychem Ltd. is engaged in manufacturing and supplying a diverse range of masterbatches, additives, and industrial chemicals used in plastics production. Its core offerings include colour masterbatches, transparent filler masterbatches, additive masterbatches, and polymer compounds. These are widely applied across industries such as packaging, automotive, electricals, consumer goods, and agriculture. The company operates with a focused product line catering to UPVC/CPVC pipe manufacturers, film processors, and moulding businesses. As of 30 September 2024, Renol Polychem employed 15 professionals across departments.

Established in: 2008
Promoters: Mr. Bhaveshbhai Mansukhbhai Harsoda

 

Peers:

Multibase India
Captain Polyplast
R M Drip and Sprinkler Systems
 

Renol Polychem Objectives

The IPO proceeds will be utilised towards:

1. Capital expenditure for acquiring new machinery to drive growth.
2. Repayment of specific borrowings to strengthen financial stability.
3. Funding incremental working capital to support day-to-day operations.
4. Allocating funds for general corporate purposes and expansion plans.
 

Renol Polychem IPO Size

Types Size
Total IPO Size ₹24.20 Cr
Offer For Sale NIL
Fresh Issue ₹24.20 Cr

 

Renol Polychem IPO Lot Size

Application Lots Shares Amount
Retail (Min) 2 2,400 ₹2,40,000
Retail (Max) 2 2,000 ₹2,40,000
S-HNI (Min) 3 3,600 ₹3,60,000
S-HNI (Max) 7 8,400 ₹8,40,000
B-HNI (Min) 8 9,600 ₹9,60,000

Renol Polychem IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
QIB 8.41 2,56,800 21,60,000 22.68
NII (HNI) 6.89 3,49,200 24,04,800 25.25
Individual Investors (IND category bidding for 2 Lots)     6.51 13,15,200 85,60,800 89.89
Total** 6.83 19,21,200 1,31,25,600 137.82

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY24 FY25
Revenue 41.86 6.52 62.56
EBITDA 1.14 2.18 7.07
PAT 0.73 1.53 5.00
Particulars (in Rs. Crores) FY23 FY24 FY25
Total Assets 10.28 15.49 23.41
Share Capital 5.49 5.49 5.49
Total Borrowings 5.36 2.58 6.95
Particulars (in Rs. Crores) FY23 FY24 FY25
Net Cash Generated From / (used in) operating activities -1.11 1.20 -1.25
Net Cash Generated From / (used in) investing activities 0.02 0.00 -0.40
Net Cash Generated From / (used in) financing activities 1.15 -0.30 3.60
Net Increase (Decrease) In Cash And Cash Equivalents 0.06 0.90 1.95


Strengths

1. Over 850% revenue growth in FY25 with PAT up by 226%
2. Strong leadership with rich management experience
3. Diverse product portfolio catering to multiple plastic applications
4. Trusted supplier relationships and efficient manufacturing capabilities

Weaknesses

1. A limited employee base may constrain rapid expansion
2. High dependency on the plastic packaging and pipe industries
3. Past fluctuations in cash flows and borrowings
4. Operational scalability risk due to machinery and labour reliance

Opportunities

1. Rising demand for advanced masterbatches in the packaging & auto sectors
2. Product customisation potential for niche applications
3. Import substitution opportunities in filler and additive segments
4. Further expansion into textile, electronics, and agri-films

Threats

1. Volatility in raw material prices could pressure margins
2. Stiff competition from global and domestic pigment suppliers
3. Regulatory shifts on plastic use and recycling norms
4. Dependency on a small client base may pose revenue risks

1. Impressive FY25 performance, Revenue and profit surged exponentially
2. Strong fundamentals backed by consistent EBITDA and PAT margins
3. Well-diversified product range serving high-demand sectors
4. Strategic capital allocation for machinery and working capital
5. Promoters with deep industry experience and stable operations

1. The polymer and masterbatch market in India is expanding rapidly due to increased demand from the packaging, automotive, consumer electronics, and infrastructure sectors. 
2. Growth in flexible packaging, EV component manufacturing, and export opportunities positions Renol Polychem favourably. 
3. Demand for customised colour and additive solutions is expected to drive further growth in the masterbatch industry.
 

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

FAQs

The Renol Polychem IPO opens on July 31, 2025 and closes on August 4, 2025.

The total issue size of Renol Polychem IPO is ₹24.20 crore, fully composed of a fresh issue of 3.05 lakh shares.

The price band of Renol Polychem IPO is ₹100 to ₹105 per share.
 

Log in to your 5paisa account, select the Renol Polychem IPO, enter the lot size and bid price, provide your UPI ID, and approve the mandate.

The minimum investment for Renol Polychem IPO is 2,400 shares (2 lots), amounting to ₹2,40,000.

Renol Polychem IPO is likely to list on NSE SME on August 7, 2025.

The allotment date of Renol Polychem IPO is tentatively set for August 5, 2025.
 

Corporate Makers Capital Ltd. is the book-running lead manager for Renol Polychem IPO.
 

The Renol Polychem IPO will utilise IPO proceeds towards:

  • Capital expenditure for acquiring new machinery to drive growth.
  • Repayment of specific borrowings to strengthen financial stability.
  • Funding incremental working capital to support day-to-day operations.
  • Allocating funds for general corporate purposes and expansion plans.